Home > Balance Sheet > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Total Non-Current Liabilities

    Back to Balance Sheet
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Total Non-Current Liabilities ₹-1,643 Cr₹-1,316 Cr₹-1,515 Cr₹246 Cr₹77 Cr

What is the latest Total Non-Current Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?

The latest Total Non-Current Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES is ₹-1,643 Cr based on Mar2023 Consolidated results.
Year Total Non-Current Liabilities
Mar2023₹-1,643 Cr
Mar2022₹-1,316 Cr
Mar2021₹-1,515 Cr
Mar2020₹246 Cr
Mar2019₹77 Cr

How is Total Non-Current Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years Total Non-Current Liabilities % Change
Mar2023 ₹-1,643 Cr
Negative
Mar2022 ₹-1,316 Cr
Negative
Mar2021 ₹-1,515 Cr
Negative
Mar2020 ₹246 Cr
220.71
Mar2019 ₹77 Cr -

Compare Total Non-Current Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹363,529.9 Cr 0.9% -6.6% 58.8% Stock Analytics
CIPLA ₹112,058.0 Cr -1% -5.6% 54.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,414.0 Cr 0.9% 2.2% 27.3% Stock Analytics
DIVIS LABORATORIES ₹103,845.0 Cr -2.2% 6.2% 21.2% Stock Analytics
ZYDUS LIFESCIENCES ₹98,676.3 Cr 2.8% -0.6% 96.2% Stock Analytics
MANKIND PHARMA ₹88,830.5 Cr -6.3% -5% NA Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

0.9%

-6.6%

58.8%

SENSEX

-1.6%

-0.5%

19.8%


You may also like the below Video Courses